News and Updates

Date:
February 13, 2014

SRT-100™ is an Optimal Therapy Modality for Non-Melanoma Skin Cancers

Featuring our SharpBeam precision superficial radiotherapy, the SRT-100™ is an excellent treatment option for patients with non-Melanoma (NMSC) skin cancers, such as Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). Ask your doctor about SRT-100™ when you weigh your treatment options!

ELEVATING DERMATOLOGICAL CARE

Stay connected with Sensus Healthcare for more news and updates. For inquiries or further information, please contact us.

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy